📰 True Human News
True Human News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from True Human. Real-time updates on events, politics, business and more.
February 18, 2024
StockNews.com assumed coverage on shares of XBiotech (NASDAQ:XBIT – Free Report) in a research report released on Thursday. The firm issued a sell rating on the biopharmaceutical company’s stock. XBiotech Stock Performance Shares of XBiotech stock opened at $5.90 on Thursday. XBiotech has a 52-week low of $3.05 and a 52-week high of $6.69. The […]
February 3, 2024
StockNews.com assumed coverage on shares of XBiotech (NASDAQ:XBIT – Free Report) in a research note published on Tuesday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. XBiotech Stock Up 17.3 % Shares of XBiotech stock opened at $5.43 on Tuesday. XBiotech has a 12 month low of $3.05 and a 12 month […]
January 26, 2024
StockNews.com started coverage on shares of XBiotech (NASDAQ:XBIT – Free Report) in a report published on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. XBiotech Price Performance XBiotech stock opened at $4.22 on Monday. The firm has a fifty day simple moving average of $4.19 and a two-hundred day simple moving […]
January 23, 2024
Acasti Pharma (NASDAQ:ACST – Get Free Report) and XBiotech (NASDAQ:XBIT – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership. Profitability This table compares Acasti Pharma and XBiotech’s […]
January 4, 2024
AUSTIN, Texas, Jan. 04, 2024 -- XBiotech Inc. today announced that it plans to expand it’s campus headquarters with the construction of a new, state-of-the-art research and development facility....
December 14, 2023
StockNews.com initiated coverage on shares of XBiotech (NASDAQ:XBIT – Free Report) in a research note issued to investors on Wednesday. The firm issued a sell rating on the biopharmaceutical company’s stock. XBiotech Trading Down 0.9 % NASDAQ:XBIT opened at $4.46 on Wednesday. XBiotech has a 1 year low of $3.00 and a 1 year high […]
December 1, 2023
StockNews.com initiated coverage on shares of XBiotech (NASDAQ:XBIT – Free Report) in a report released on Monday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. XBiotech Price Performance XBiotech stock opened at $3.92 on Monday. The firm has a 50 day simple moving average of $3.93 and a 200-day simple moving […]
November 30, 2023
StockNews.com assumed coverage on shares of XBiotech (NASDAQ:XBIT – Free Report) in a research report report published on Monday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. XBiotech Stock Performance Shares of NASDAQ:XBIT opened at $3.71 on Monday. XBiotech has a 52-week low of $3.00 and a 52-week high of $6.69. […]
November 23, 2023
StockNews.com started coverage on shares of XBiotech (NASDAQ:XBIT – Free Report) in a research note released on Sunday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. XBiotech Stock Performance Shares of NASDAQ:XBIT opened at $3.58 on Friday. The company has a fifty day moving average of $4.03 and a 200-day moving […]
November 22, 2023
StockNews.com initiated coverage on shares of XBiotech (NASDAQ:XBIT – Free Report) in a report published on Sunday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. XBiotech Trading Down 2.5 % Shares of NASDAQ XBIT opened at $3.56 on Friday. The stock has a market cap of $108.37 million, a price-to-earnings ratio […]